Actively Recruiting
A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease
Led by University of Sydney · Updated on 2025-04-04
400
Participants Needed
4
Research Sites
164 weeks
Total Duration
On this page
Sponsors
U
University of Sydney
Lead Sponsor
M
Monash University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to compare REBUILD-SM (a purpose-built smartphone app and self-management package) with standard care in people with interstitial lung disease (ILD). The main question it aims to answer is: • Does REBUILD-SM improve health-related quality of life, symptoms, anxiety, self-efficacy and physical activity for people with ILD? Participants in the intervention group will work through the self-management package with support from a healthcare professional via phone or Zoom. They will also enter deidentified health data into the RE-BUILD smartphone app to track their progress over time. Participants in the control group will use a reduced functionality version of the smartphone app only. Researchers will compare both groups to see if there is any difference in health-related quality of life, symptoms, anxiety, self-efficacy and level of physical activity.
CONDITIONS
Official Title
A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of fibrotic interstitial lung disease (ILD)
- Own a smartphone or tablet and have an email address
- Able to understand written and spoken English
- Have adequate digital skills to complete the study requirements
- On stable ILD treatment for at least 30 days before joining the study
You will not qualify if you...
- Do not have a smartphone or tablet
- Insufficient digital skills to complete the study requirements
- Unable to communicate in written or spoken English
- Not on stable ILD treatment for at least 30 days before joining
- Had an acute exacerbation of ILD within 30 days before joining
- Currently participating in pulmonary rehabilitation or plan to during the 12-week study period
- Unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Royal Prince Alfred Hospital
Sydney, New South Wales, Australia, 2050
Actively Recruiting
2
The Prince Charles Hospital
Brisbane, Queensland, Australia, 4032
Actively Recruiting
3
Alfred Hospital
Melbourne, Victoria, Australia, 3004
Actively Recruiting
4
Austin Health
Melbourne, Victoria, Australia, 3084
Actively Recruiting
Research Team
C
Carly Barton
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here